India proposes BRICS consortium to tackle post-COVID challenges, NCDs as flagship programme Medical Dialogues Bureau30 May 2021 9:00 AM ISTFrom the Indian side, key scientific institutions that participated include the DST, Department of Biotechnology (DBT), Indian Institute of Technology...
Bajaj Healthcare launches black fungus drug Posaconazole API for COVID patients Ruchika Sharma29 May 2021 12:22 PM ISTPosaconazole is a triazole antifungal agent indicated for treating Mucormycosis patients.
Pfizer, Govt working on speedy import of COVID vaccine, says VK Paul Ruchika Sharma28 May 2021 10:00 AM ISTNew Delhi: As soon as Pfizer indicated vaccine availability, the central government and the company started working together for the earliest possible...
NHRC directs Health Ministry, Delhi Govt to act on treatment deficiency, negligence at Delhi hospitals Medical Dialogues Bureau28 May 2021 9:45 AM IST"The Government of NCT of Delhi failed to provide timely treatment/medical care for his head injuries under the plea that beds are not available in...
Zydus Cadila seeks DCGI nod for clinical trials of monoclonal antibodies cocktail that neutralises COVID infection Ruchika Sharma27 May 2021 11:30 AM ISTZRC-3308 is a cocktail of two monoclonal antibodies targeting two unique epitopes on the spike protein of SARS-COV-2.
Govt eyes securing part of JnJ COVID vaccine to be manufactured by Biological E for India: Report Ruchika Sharma27 May 2021 10:00 AM ISTNew Delhi: Johnson and Johnson's Covid-19 vaccine to be manufactured in India by Biological E cannot be directly channelled to the domestic market and...
Vaccine Status: Wait for Moderna till next year but Pfizer ready to offer in 2021 Ruchika Sharma26 May 2021 1:22 PM ISTNew Delhi: Moderna is expecting to launch a single-dose Covid-19 vaccine in India next year and is in talks with Cipla among other Indian firms, while...
Bharat Biotech expects WHO emergency use listing for Covaxin in July-September Ruchika Sharma26 May 2021 1:10 PM ISTHyderabad: Bharat Biotech on Tuesday said it expects approval for its COVID-19 vaccine Covaxin from the World Health Organisation for Emergency Use...
MSN Labs begins COVID drug Molnupiravir phase III trial Ruchika Sharma26 May 2021 12:23 PM ISTMolnupiravir is an experimental drug having antiviral properties and is currently under clinical-stage study for COVID treatment.
Bharat Biotech American partner submits Covaxin Master File to USFDA Ruchika Sharma26 May 2021 11:37 AM ISTIn an investor presentation, Ocugen said it is expecting the vaccine to be rolled out in the US during the second half of the current year.
FLCCC releases COVID-19 Hospital Treatment Protocol Hina Zahid25 May 2021 10:00 PM IST-New York, New York - The Frontline COVID-19 Critical Care Alliance (FLCCC) announces that their highly effective, combination therapy treatment...
Bal Pharma launches Favipiravir under brand name BALflu Ruchika Sharma25 May 2021 1:11 PM ISTBALflu has the efficacy to clear the virus faster by 28.7% and is marketed at a very affordable price of Rs. 85 per tablet, said Managing Director...
